Low birth weight (LBW) and premature birth are known risk factors for future cardiovascular disease and in particular essential hypertension (EH). Capillary rarefaction (CR) is an established hallmark of EH and is known to occur in individuals with a history of LBW. We previously reported that LBW infants do not have CR at birth but rather increased capillary density (CD). We hypothesized that LBW infants undergo a process of accelerated CR in early life, triggered in part by oxygen therapy. We studied 26 LBW infants, of whom 10 infants received oxygen therapy, and compared them to 14 normal birth weight (NBW) infants. We measured CD at 1, 5 and 10 days after birth and again after 40 weeks adjusted gestational age equivalent to birth at full term. We confirmed that LBW infants had higher CD at birth compared to NBW infants and found that significant structural CR occurred at term age in LBW infants who had received oxygen therapy (mean difference −22 capillaries/field, p = 0.007) and in those who did not receive oxygen therapy (mean difference −29 capillaries/field, p < 0.001) compared to baseline at birth. Both LBW groups showed a significant rise in BP at 40 weeks adjusted term age and the rise in systolic (mean difference 24 mm Hg, p < 0.0001) and diastolic BP (mean difference 14 mm Hg, p < 0.001) was more pronounced in the oxygen treated group compared to the nonoxygen group (mean difference 14 mm Hg, p = 0.043 and mean difference = 9 mm Hg p = 0.056 respectively). In conclusion, oxygen therapy in premature LBW infants may induce significant increases in their BP in early life.
Introduction
Low birth weight (LBW <2500 g) is a recognized risk factor for the development of future essential hypertension (EH), ischemic heart disease, diabetes mellitus, obesity, and increased cardiovascular mortality in adult life [1, 2] . The pathophysiological mechanisms are yet to be elucidated, however, it has been suggested that microcirculatory abnormalities and impaired tissue perfusion are implicated in the pathogenesis of these cardiovascular disorders [3] . It is thought that the suboptimal in-utero conditions that impair the fetal growth in the first instance may affect the microvasculature and result in many structural and functional abnormalities including the reduction in spatial density of capillaries or capillary rarefaction (CR) [4] . We have previously reported that much of the CR in EH is caused by the structural absence of capillaries [5] . We have also shown significant CR in patients with borderline intermittent EH and in normotensive offspring of hypertensive parents, suggesting a familial predisposition in which CR represents a primary vascular abnormality that antedates the onset of sustained elevation of blood pressure (BP) [6, 7] . We recently reported the unexpected finding that LBW infants born at term or preterm to normotensive mothers do not have CR: instead these infants have a significantly higher dermal CD at birth compared to their normal birth weight (NBW) counterparts [8] . It is becoming increasingly evident that conditions early in life can influence adult diseases. It has been reported in some studies that hyperoxia during the neonatal period may have a negative effect on the cardiovascular system [9] . We hypothesized that the high capillary density seen in the LBW infants at birth was an inutero compensatory adaptation to unfavorable conditions and that after birth, with the availability of adequate nutrition and more importantly oxygen, an accelerated capillary remodeling then ensues [10, 11] . We set out to test our hypothesis by conducting serial measurements of skin capillary density in LBW preterm infants receiving oxygen therapy.
Methods

Study subjects
The study was approved by the London -Riverside Research Ethics Committee (13/LO/1449) and was conducted at St. George's University Hospitals NHS Foundation Trust, London, UK. Written informed consent was obtained from all parents. The infants in the study were recruited from the neonatal intensive care unit (NICU), Transitional Care Unit and the Postnatal Ward. We studied 26 LBW infants (<2500 g and ≥30 weeks of gestation) and 14 NBW infants as controls. As this was a pilot pragmatic study, no official power calculation was done to determine sample size. We excluded infants with sepsis, chromosomal or congenital abnormalities and those requiring surgery. The antenatal history of the mothers and details of the findings during the anomaly ultrasound scan were also recorded. Dietary habits, smoking history, family history of diabetes, ischemic heart disease, stroke, hypercholesterolemia, and hypertension were obtained from both parents.
Handheld Video Capillaroscopy System (HVCS)
CapiScope Handheld Video Capillaroscopy System (HVCS, KK technology, Devon, England) was used to measure skin capillary density at the plantar surface of the infant big toe according to a previously well-validated protocol [8, 12, 13] . The size of the microscopic field was 0.81 mm 2 , with an image size of 1280 × 1024 pixels and a field view of 1037 × 829 pixels. The optical illumination of the HVCS device was done using four 525 nm light sources. The live images were recorded onto a Panasonic DMR-EX99VEBK HDD recorder. Disposable sterile probe covers were used for imaging to minimize the risk of infection. Four microscopic fields, 0.81 mm 2 each, were recorded continuously for 30 s. The number of all capillaries (i.e., with stagnant, intermittently flowing and continuously flowing red blood cells) was counted. Basal capillary density (BCD), which represents functional capillary density, was calculated as the mean of these four microscopic fields. We used venous congestion to maximize the number of visualized perfused skin capillaries by applying a neonatal BP cuff (Heine Gamma 7 Sphygmomanometer, Germany) around the calf muscle. The cuff was then inflated and maintained at 30 mm Hg for 2 min, and further images were recorded continuously for 2 min to determine the maximal capillary density (MCD), which represents structural capillary density. Capillaries were counted off line using the CapiScope computer software (KK-Technology, Exeter, UK). Skin temperature was monitored during the study using an YSI Tele-thermometer (YSI Inc., Dayton, OH, USA).
In LBW infants not receiving oxygen therapy, capillaroscopy was performed immediately after birth (baseline measurement) provided the cardiorespiratory status was stable and repeat follow-up measurements were done after 5 days and 10 days. The baseline measurement in LBW infants requiring oxygen treatment was slightly delayed due to the medical condition of the infants. In preterm LBW infants an additional measurement of capillary density was taken at the corrected (i.e. 40 weeks) term age prior to their discharge from hospital or by visiting them at home. In the NBW group we measured capillary density at birth only before mothers were discharged from the hospital. Blood and urine samples were obtained from the infants.
BP measurement
We used the Welch Allyn VSM 300 TM series monitor to measure BP in infants at each visit while they were sleeping or feeding to avoid movement artefacts. An appropriate sized disposable Welch Allyn neonatal cuff (size, 1-4) was used to measure the BP. All measurements were taken in the lower limb, as this was the easily accessible part to the neonate inside the incubator.
Proteome array
Blood samples were obtained from 13 LBW infants during their stay in the ICU by venepuncture or heel prick method. The samples were allowed to clot for 30 min and after centrifugation the serum was aliquoted and stored at −80°C
. Two hundred and one cytokines were measured by the Quantibody Human Cytokine Antibody Array 4000 (RayBiotech, Norcross, GA, USA) according to manufacturer's instructions.
Statistical analysis
The primary endpoint was the change in maximal (structural) skin capillary density during venous congestion (MCD) between birth to adjusted age of 40 weeks postnatal life. Shapiro-Wilk test was used to assess the normality of study parameters. ANOVA test with Bonferroni correction was used for comparison of means among the groups.
Student's t test was used to compare the difference of capillary density measurement from baseline to the corrected term age in the preterm LBW infants. Chi-square test was used to compare proportions between the LBW and NBW mothers. Pearson correlation coefficient was used to describe the linear correlation between capillary density and birth weight and changes in BP. Statistical significance was declared when the p-value was <0.05. All statistical analysis was carried out using the IBM SPSS 22 (IBM Corporation, Armonk, NY, USA). Table 1 shows the baseline characteristics of study subjects. There were no significant differences in maternal age, body mass index, booking BP (i.e. BP measured during the first antenatal clinic visit), pulsatility index, or ultrasound fetal parameters during the anomaly scan between the groups. Of the 26 LBW infants we studied, 10 received oxygen treatment either by continuous positive airway pressure, mechanical ventilation, or a nasal cannula.
Results
At birth, LBW infants had a significantly higher BCD (mean difference +9.3 cap/field, 95% CI: 1.5-17.1, p = 0.021) and MCD (mean difference +11.6 cap/field, 95% CI: 1.6-21.7, p = 0.025) compared to the NBW infants. Compared to their NBW counterparts, LBW infants had a significantly lower diastolic BP (mean difference −10.1 mm Hg, 95%CI: −17.7 to −2.6, p = 0.010) (Fig. 1) . There was no significant difference in systolic BP. Pulse rate was significantly higher in LBW (mean difference 15.1 ± 10.1 beats/min, 95%CI: 3.4-26.8, p = 0.013). There was a significant correlation between birth weight and both BCD (r = −0.309, p = 0.052), and MCD in the entire group (r = −0.355, p = 0.025).
At adjusted age of 40 weeks, the LBW oxygen group showed a significant reduction in BCD (mean difference −20.4 cap/field, 95%CI: −7.2 to −33.6, p = 0.009) and MCD (mean difference −20.6 cap/field, 95%CI: −3.7 to −37.5, p = 0.025) compared to baseline values at birth. Similarly the LBW nonoxygen group had a significant reduction in BCD (mean difference −26.7 cap/field, 95%CI −16.3 to −37.1, p < 0.0001) and MCD (mean difference −28.2 cap/field, 95%CI, −17.1 to −39.2, p < 0.001). There were no significant differences in BCD and MCD between the two LBW groups. The reduction in CD was associated with a significant rise in systolic (r = −0.385, p < 0.035), and diastolic BP (r = −0.361, p < 0.050) in both LBW groups. The rise in systolic BP and diastolic BP was more pronounced in the LBW oxygen group (mean difference 24 mm Hg, 95%CI: 4-11, p = 0.004 for systolic BP, and mean difference 11 mm Hg, 95%CI: 3-19, p = 0.014 for diastolic BP) compared to the LBW nonoxygen group (mean difference 16 mm Hg, 95%CI: 4-6, p = 0.005 and mean difference 13 mm Hg, 95%CI: 3-4, p = 0.01, respectively) ( Table 2) .
We found no significant differences in angiogenic or antiangiogenic factors between the two LBW groups. Macrophage colony-stimulating factor was significantly lower in the LBW oxygen group compared to the LBW nonoxygen group (0.656 ± 0.389 versus 0.217 ± 0.195 pg/ ml, p < 0.035), but we are unable to explain the significance of this finding.
Discussion
The study demonstrates that premature LBW infants who received oxygen therapy developed significant functional and structural CR, which was associated with a significant increase in both systolic and diastolic BPs at adjusted 40 weeks of age. We also found that LBW infants who did not receive oxygen therapy developed similar CR, but the increase in their BP was not as significant as in those who received oxygen therapy. In addition, we confirmed our previous report that LBW infants have higher functional and structural capillary densities at birth compared to NBW infants [8] . The effect of preterm birth on microvascular development has also been highlighted by studies showing reduced retinal vascular caliber and density (independently of retinopathy of prematurity), as well as reduced cutaneous capillary density in children and young adults born very preterm [14, 15] . As previously stated, it has become increasingly evident that conditions early in life can influence adult diseases, but the underlying mechanisms are unkown [16] . Recent data suggest that perinatal oxidative stress may be one of the initiating triggers in long-term programming of cardiovascular function. Our results are in agreement with several preclinical studies. In animal models, the continuous supplementation of oxygen has been shown to affect the development of microvasculature and to induce vascular obliteration and CR [17, 18] and an increase in BP [19] . Yzydorczyk et al. [9] studied Sprague-Dawley pups who were exposed to 80% oxygen from 3-10 days after birth and found that in both male and female rats exposed to oxygen as newborns, systolic, and diastolic BP were increased by about 15 mm Hg, capillary density was reduced by 30% and the number of nephrons per kidney was decreased by 25%. They suggested that neonatal hyperoxia leads in the adult rat to increased BP, vascular dysfunction, CR, and reduced nephron number. It has been shown that the nephron numbers are decreased in adult individuals with EH [20] and in intrauterine growth-restricted infants [21, 22] .
Milstein et al. [19] studied sublingual microvascular vessel density, vessel diameters, and microvascular flow in rabbits breathing sequential oxygen/air mixtures under normobaric and hyperbaric conditions. They found that normobaric hyperoxia produced significant microvascular rarefaction and significant increases in systolic and mean BP when compared to normobaric normoxia. Of interest they found that all microcirculatory abnormalities reverted back to normal values upon return to normoxia. Ashton et al. [23] confirmed that 80% inspired oxygen in healthy kittens caused "vaso-obliteration" of the newly formed capillaries; when the animals were returned to ambient air, a "vaso-proliferative" effect was observed causing retinopathy of prematurity. Oxygen supplementation in humans during the neonatal period has proven adverse effects on the microvascular circulation especially in the retina and the lungs. However it has been shown previously that capillary density ordinarily decreases after birth in preterm infants who did not receive oxygen therapy. Kroth et al. measured basal or functional small vessel density (FSVD) in 25 preterm infants born <30 weeks old using orthogonal polarization spectral imaging on their upper arm. They found that FSVD decreased at 4 weeks compared to week 1. However, they did not observe any significant change in BP, but observed a negative correlation between FSVD and systolic BP [24] . Similarly van Elteren et al. [25] measured total vascular density (TVD) using incident dark field technology in 60 preterm infants born less than 32 weeks and 33 term infants during the first month of life. Similar to us, they found that TVD was higher in preterm infants at birth and that there was a progressive decline in TVD from birth to 28 days in preterm infants.
Our results corroborate with Kistner et al. who found that preterm-born women had significant rarefaction of retinal vessels manifested as fewer numbers of vascular branching points compared with NBW controls. This was associated with an increased casual BP suggesting that being born preterm does have effects on the vascular system that persist into adult life [15] .
It has been reported that premature infants have decreased antioxidant defenses and are exposed upon birth to high oxygen concentration relative to the intrauterine environment [26] . Additional oxygen therapy may therefore cause oxidative tissue damage, leading to pathologies such as retinopathy of prematurity and broncho-pulmonary dysplasia [27] . More recent studies indicate that individuals with a history of premature birth exhibit higher BP levels and abnormal retinal microvasculature and parameters of cardiovascular dysfunction [15, 28] . While the mechanisms linking prematurity to adult cardiovascular disorders are unknown, our data and that from others support a putative role for neonatal oxidative stress. Oxidative stress has been shown to be involved in the promotion of rarefaction through endothelial apoptosis in hypertensive rats, while treatment with antioxidants has resulted in a reduction of microvessel loss [29] .
We acknowledge the limitations in our study that include the small numbers of LBW infants treated with oxygen, but this highlights the difficulties in recruiting such infants while they are in the NICU. The ethnicity of infants was not even in study groups and the significant difference in the age of infants on the study day may have been a confounding factor [30] . However, we assessed BCD and MCD in NBW term infants of different ethnic backgrounds born to normotensive mothers and found no difference in capillary density between the different groups (unpublished data). There was also significant variability in the mode of oxygen therapy, duration and percentage of fractional percentage of inspired oxygen (FiO 2 ) received in the postnatal period. It was not possible to control for the above factors, or render them uniform for the study, as they were tailored according to the clinical needs of each preterm infant. The timing of baseline measurement in the LBW oxygen group was slightly delayed compared to the nonoxygen group because of limited access to the NICU due to the medical condition of the baby. However, the mean gestational age was closely matched during the serial measurement of capillary density between the groups. All the blood samples were taken within the first 2 weeks in the NICU as we aimed for the blood sampling to coincide with routine clinical blood sampling to avoid additional discomfort to the baby. Similarly, BP measurements were taken only once, again to avoid undue discomfort to the infants. We have previously observed that sequential BP measurements LBW low birth weight, NBW normal birth weight awaken infants and disturb them, such that second and third readings were almost always higher than the first reading.
We therefore ensured that all the BP measurements were taken while the baby was sleeping or feeding to minimize any artefacts.
In conclusion, oxygen therapy in premature LBW infants in the neonatal period is associated with higher systolic and diastolic BP levels, but has no significant effect on the rate of capillary reduction from birth to adjusted age of 40 weeks. Further studies are needed to investigate the humoral factors that trigger the microcirculatory changes in LBW infants during the neonatal period, which will be of importance in preventing future hypertension and cardiovascular diseases in later life.
Summary table
"What is known about topic"
• LBW and premature birth are known risk factors for future cardiovascular disease and in particular EH.
• CR is an established hallmark of EH and is known to occur in individuals with a history of LBW.
• It has been shown recently that LBW infants do not have CR at birth, but rather increased capillary density compared to NBW.
• In preclinical animal studies, oxygen therapy has been shown to induce vascular obliteration and CR in the new born.
"What this study adds"
• Oxygen therapy in premature LBW infants in the neonatal period is associated with higher systolic and diastolic BP levels but has no significant effect on the rate of capillary reduction.
• Further studies are needed to investigate the humoral factors that trigger the microcirculatory changes in LBW infants during the neonatal period, which will be of importance in preventing future hypertension and cardiovascular diseases in later life. 
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